Immunostaging in carcinoma of prostate

Patrick D. Guinan; Richard J. Ablin; Edgar R. Rios; H. Al Sheik; Irving M. Bush

doi:10.1016/0090-4295(76)90306-X

Immunostaging in carcinoma of prostate

Patrick D. Guinan, Richard J. Ablin, Edgar R. Rios, H. Al Sheik, Irving M. Bush

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Immunostaging is a new method of assessing patients immunologically before and after immunotherapy. Twenty-eight patients with adenocarcinoma of the prostate were immunostaged independently by two investigators. There was a positive correlation between both immunostagings. There was also a positive correlation between the patient's immunostage and the clinical stage of his cancer.

Original language	English (US)
Pages (from-to)	178-180
Number of pages	3
Journal	Urology
Volume	7
Issue number	2
DOIs	https://doi.org/10.1016/0090-4295(76)90306-X
State	Published - Feb 1976
Externally published	Yes

ASJC Scopus subject areas

Urology

Access to Document

10.1016/0090-4295(76)90306-X

Cite this

@article{7bae5442b765470f8b3fdf81fe9308a7,

title = "Immunostaging in carcinoma of prostate",

abstract = "Immunostaging is a new method of assessing patients immunologically before and after immunotherapy. Twenty-eight patients with adenocarcinoma of the prostate were immunostaged independently by two investigators. There was a positive correlation between both immunostagings. There was also a positive correlation between the patient's immunostage and the clinical stage of his cancer.",

author = "Guinan, {Patrick D.} and Ablin, {Richard J.} and Rios, {Edgar R.} and {Al Sheik}, H. and Bush, {Irving M.}",

year = "1976",

month = feb,

doi = "10.1016/0090-4295(76)90306-X",

language = "English (US)",

volume = "7",

pages = "178--180",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Immunostaging in carcinoma of prostate

AU - Guinan, Patrick D.

AU - Ablin, Richard J.

AU - Rios, Edgar R.

AU - Al Sheik, H.

AU - Bush, Irving M.

PY - 1976/2

Y1 - 1976/2

N2 - Immunostaging is a new method of assessing patients immunologically before and after immunotherapy. Twenty-eight patients with adenocarcinoma of the prostate were immunostaged independently by two investigators. There was a positive correlation between both immunostagings. There was also a positive correlation between the patient's immunostage and the clinical stage of his cancer.

AB - Immunostaging is a new method of assessing patients immunologically before and after immunotherapy. Twenty-eight patients with adenocarcinoma of the prostate were immunostaged independently by two investigators. There was a positive correlation between both immunostagings. There was also a positive correlation between the patient's immunostage and the clinical stage of his cancer.

UR - http://www.scopus.com/inward/record.url?scp=0017275958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017275958&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(76)90306-X

DO - 10.1016/0090-4295(76)90306-X

M3 - Article

C2 - 1108352

AN - SCOPUS:0017275958

SN - 0090-4295

VL - 7

SP - 178

EP - 180

JO - Urology

JF - Urology

IS - 2

ER -

Immunostaging in carcinoma of prostate

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this